Small-cap biotech still ‘under-valued’ vs big cap
With RTW Ventures continuing to invest in small-cap biotech and pharmaceutical companies, Stephanie Sirota, a director of RTW Investments, says there is still value to be had.
Related articles
Live prices on most popular markets
- Equities
- Indices
- Forex
- Commodities
Prices above are subject to our website terms and agreements. Prices are indicative only. All share prices are delayed by at least 15 minutes.
Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.